Tony Charman
Chair of clinical child psychology
King's College London
From this contributor
Building an autism research registry: Q&A with Tony Charman
A purpose-built database of participants who have shared genomic and behavioral data could give clinical trials a boost, Charman says.
Building an autism research registry: Q&A with Tony Charman
Your questions about the Lancet Commission and ‘profound autism,’ answered
Tony Charman and Catherine Lord answer questions from Spectrum’s webinar on the Lancet Commission’s recommendations for autism research.
Your questions about the Lancet Commission and ‘profound autism,’ answered
Separate thinking skills underlie autism, attention deficit
Theory of mind difficulties are likely to be more central to autism than to attention deficit hyperactive disorder, whereas executive function problems are more often associated with the latter.
Separate thinking skills underlie autism, attention deficit
Tony Charman: Longitudinal studies for autism research
Clinicians and autism researchers should learn the early signs of autism and take into account an individual’s developmental trajectory, says Tony Charman.
Tony Charman: Longitudinal studies for autism research
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.